ArticleFolia microbiologica2020
Remedial potential of bacterial and fungal strains (Bacillus subtilis, Aspergillus niger, Aspergillus flavus and Penicillium chrysogenum) against organochlorine insecticide Endosulfan.
Article in Folia microbiologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 39 citations in OpenAlex.
- The ability of selected fungal strains to produce carboxylesterase enzymes for biodegradation and use of bifenthrin insecticide as carbon source: in vitro and in silico approaches.Bioprocess and biosystems engineering · 2024Article
- Biotransformation of selected secondary metabolites by Alternaria species and the pharmaceutical, food and agricultural application of biotransformation products.Natural products and bioprospecting · 2024Review
- Environmental Detoxification of Benzimidazole Fungicide Fuberidazole via Microbial Action in Liquid Cultures.Mycobiology · 2024Article
- Review on Performance ofMicroorganisms · 2023Review
- Evaluation of endosulfan degradation capacity by six pure strains isolated from a horticulture soil.Folia microbiologica · 2021Article
- Myco-remediation of Chlorinated Pesticides: Insights Into Fungal Metabolic System.Indian journal of microbiology · 2021Review
- Mass spectrometry-based identification of bacteria isolated from industrially contaminated site in Salamanca (Mexico) and evaluation of their potential for DDT degradation.Folia microbiologica · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endosulfan, an organochlorine insecticide, is known to cause detrimental effects to the environment and human health due to its excessive usage. Its highly toxic nature calls for an environmental-friendly approach for its detoxification. Environmental transformation of Endosulfan was assessed through biodegradation by isolated and cultured soil microbes (Bacillus subtilis (BS), Aspergillus niger (AN), Aspergillus flavus (AF) and Penicillium chrysogenum (PC)). Degradation of 10 mg/L Endosulfan was determined in aqueous solution at regular time intervals and analysed by gas chromatography-mass spectrometry for 35 days. BS and AN displayed substantial potential to degrade Endosulfan and subsequently transform it into its daughter products (95 and 77%, respectively). Endosulfan transformation followed first-order reaction kinetics. Chromatogram peaks revealed less toxic metabolites by Endosulfan transformation (Endosulfan diol, Endosulfan ether, Endosulfan hydroxyether and Endosulfan lactone). Half-life of Endosulfan obtained by various strains utilised in the experiments was in the order, PC (69) > AF (34.6) > AN (17.3) > BS (11.5) days. Statistical analysis was performed in MINITAB to evaluate the significance of results. Bioaugmentation of contaminated sites with such efficient microbes can facilitate rapid pesticide transformation and decontamination of the environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.